Disposition of 2531 shares by Sun Kevin M of DermTech at 0.88 subject to Rule 16b-3
DMTKDelisted Stock | USD 0.04 0.02 71.36% |
About 56% of all DermTech's institutional investors are looking to take a long position. The analysis of current outlook of investing in DermTech suggests that some traders are interested regarding DermTech's prospects. DermTech's investing sentiment shows overall attitude of investors towards DermTech.
DermTech |
Filed transaction by DermTech Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
DermTech Fundamental Analysis
We analyze DermTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DermTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DermTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
DermTech is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
DermTech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DermTech stock to make a market-neutral strategy. Peer analysis of DermTech could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics with similar companies.
Peers
DermTech Related Equities
CURI | Curiositystream | 1.38 | ||||
OM | Outset Medical | 1.27 | ||||
CLPT | Clearpoint Neuro | 0.17 | ||||
FLGT | Fulgent Genetics | 3.80 | ||||
TMDX | TransMedics | 4.34 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in DermTech Stock
If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data |